Drug Profile
Hirunorm
Latest Information Update: 23 Sep 1998
Price :
$50
*
At a glance
- Originator Guidotti
- Class Antithrombotics; Peptides
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 23 Sep 1998 No-Development-Reported for Thrombosis in Italy (Unknown route)
- 17 Dec 1996 New profile
- 17 Dec 1996 Preclinical development for Thrombosis in Italy (Unknown route)